Related Experiment Video
Updated: Jul 4, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Aspergillus and the Lung
Iris Janssens1,2,3, Bart N Lambrecht1,2,3,4, Eva Van Braeckel1,2
1Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Abstract:
The filamentous fungus Aspergillus causes a wide spectrum of diseases in the human lung, with Aspergillus fumigatus being the most pathogenic and allergenic subspecies. The broad range of clinical syndromes that can develop from the presence of Aspergillus in the respiratory tract is determined by the interaction between host and pathogen. In this review, an oversight of the different clinical entities of pulmonary aspergillosis is given, categorized by their main pathophysiological mechanisms. The underlying immune processes are discussed, and the main clinical, radiological, biochemical, microbiological, and histopathological findings are summarized.
Insights
Pulmonary aspergillosis, caused by Aspergillus, presents diverse lung diseases. This review categorizes clinical entities by pathophysiology and summarizes key diagnostic findings.
Area of Science:
- Medical Mycology
- Pulmonology
- Immunology
Background:
- Aspergillus, a filamentous fungus, causes significant lung diseases, with Aspergillus fumigatus being particularly pathogenic and allergenic.
- The clinical presentation of pulmonary aspergillosis is highly variable and depends on the complex interplay between the host's immune system and the fungus.
- Understanding these host-pathogen interactions is crucial for diagnosing and managing the spectrum of aspergillosis-related lung conditions.
Approach:
- This review provides a comprehensive overview of pulmonary aspergillosis.
- Clinical entities are systematically categorized based on their primary pathophysiological mechanisms.
- Key diagnostic findings across clinical, radiological, biochemical, microbiological, and histopathological domains are summarized.
Key Points:
- Pulmonary aspergillosis encompasses a range of diseases driven by Aspergillus species.
- Pathophysiological mechanisms dictate the diverse clinical manifestations.
- Diagnostic evaluation requires integrating findings from multiple modalities.
Conclusions:
- A clear understanding of the pathophysiological basis of pulmonary aspergillosis aids in clinical differentiation.
- Comprehensive diagnostic summaries support accurate identification and management of lung infections caused by Aspergillus.
- Further research into host-pathogen interactions can refine therapeutic strategies for aspergillosis.
Related Concept Videos
Other Pulmonary Disorders
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

